Data / Form D filings / Galecto, Inc.
Galecto, Inc.: Form D filings
Galecto, Inc., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2020 and 2025. The latest, on November 21, 2025, reports $285 million sold of a $285 million offering to 48 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 75 State Street, Suite 100, Boston, MA, 02109
- Phone
- (457) 070-5210
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1800315
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | New notice | $285,000,000 | $285,000,000 | 48 | Nov 12, 2025 | sec.gov | |
| Nov 5, 2020 | New notice | $64,199,679 | $64,199,679 | 42 | Sep 25, 2020 | sec.gov | |
| Jan 16, 2020 | New notice | $123,718,248 | $79,143,223 | $44,575,025 | 35 | Dec 31, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher T. Cain | Director | |
| Garrett T. Winslow | Executive Officer | |
| Carl T. Goldfischer | Director | |
| Lori T. Firmani | Executive Officer | |
| Peter T. Harwin | Director | |
| Amit T. Munshi | Director | |
| Hans T. Schambye | Executive Officer, Director | |
| Jayson T. Dallas | Director | |
| Julianne T. Bruno | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Nov 17, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Galecto, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.